Poster

CTAD 2025: Evaluating a Personalized Endpoint in Down Syndrome-Associated Alzheimer's Disease: Feasibility and Stakeholder Perspectives

December 1, 2025
 - 
December 4, 2025
View Poster

Uncover partnership opportunities with Ardea Outcomes

Partner with us to unlock possibilities for patient-centric trials. Together, we'll drive patient-focused drug development programs forward and transform lives.

Discover How
Services
GAS ExpertiseGoalNav® Training & Software
About
LeadershipOur CultureCareersContact
Resources
Our PublicationsGAS LibraryPostersWebinars
News & Events
NewsEvents
Black lowercase letters 'in' on a white square background, representing the LinkedIn logo.White stylized X logo with a diagonal cutout on a black background.
© Ardea Outcomes 2024. All rights reserved. Privacy policy.